Opendata, web and dolomites

PREDICT SIGNED

Big Data EEG-Analysis for Advanced Personalised Medicine in Depression

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PREDICT project word cloud

Explore the words cloud of the PREDICT project. It provides you a very rough idea of what is the project "PREDICT" about.

substantiation    compare    98    equal    prevents    countless    eluded    accounting    therapies    mdd    predict    savings    diagnosis    accurately    weight    patients    million    individual    doctors    delays    disorders    reduces    validated    ownership    easily    medicine    remission    suffer    responsiveness    slows    functions    diagnose    rates    trial    truly    gdp    personalised    metrics    rarely    electroencephalogram    dramatically    measured    quality    tool    tms    antidepressants    day    biomarkers    elminda    costly    hinders    life    52    health    organ    treatment    predicts    invasive    33    measuring    treatments    right    modern       suspected    body    fat    total    amelioration    normal    treat    equivalent    healthcare    ranges    ailments    disorder    symptoms    depressive    mental    psa    quantifying    time    event    brains       receiving    improves    people    percentage    unable    cholesterol    brain    population    temperature    prescribed    patient    heavy    determines    error   

Project "PREDICT" data sheet

The following table provides information about the project.

Coordinator
ELMINDA LTD 

Organization address
address: Shenkar 1, WeWork Building
city: HERZLIYA
postcode: 4673314
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 2˙798˙450 €
 EC max contribution 1˙958˙915 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2021-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    ELMINDA LTD IL (HERZLIYA) coordinator 1˙958˙915.00

Map

 Project objective

Modern medicine has given us countless methods of understanding, measuring and managing such metrics of our health as temperature, weight, body fat percentage, cholesterol, PSA values, etc. A patient’s measured values are easily compared against well-established normal ranges. And yet a simple, non-invasive method for measuring and quantifying the health of our brains has eluded us. Being unable to accurately measure and compare how a brain functions hinders doctors’ ability to diagnose and treat suspected ailments. It also slows the substantiation of new therapies. And, just as importantly, it prevents each of us from truly understanding and taking ownership of the health of our body’s most important organ. Major Depressive Disorder (MDD) has been identified as the leading and most costly mental disorder, accounting for 33% of the total cost of brain disorders, and equal to 1% of the GDP. Each year, about 7% of the population suffer from MDD in Europe, equivalent to 52.98 million people. The current methods of treatment are prescribed through trial and error with patients rarely receiving the ‘right’ treatment from day one. This reduces response rates and delays remission, which has a heavy impact on the individual’s quality of life. elminda has developed the “PREDICT” tool which predicts responsiveness to antidepressants and TMS treatment, and thus dramatically reduces time from diagnosis to amelioration of symptoms for MDD patients. PREDICT determines personalised treatments for MDD patients based on validated electroencephalogram and event-related potential brain-related biomarkers. The tool predicts responsiveness to antidepressants and TMS treatment, and thus dramatically reduces time from diagnosis to amelioration of symptoms. This improves response rates, quality of life and results in significant savings for the healthcare systems.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PREDICT" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PREDICT" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Preemie (2019)

Personalised nutrition of low-birth-weight infants

Read More  

ALR4000 (2019)

Automated LCD Recycling series 4000

Read More  

Proteus 25 (2018)

Developing the world’s first food wrapping machine with organic film

Read More